# Grant A. Krafft

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/grant-a-krafft/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,173 |
| Field | Alzheimer's disease research and treatments |
| h-index | 44 |
| i10-index | 69 |
| Last Known Institution | Acumen Pharmaceuticals (United States) |
| OpenAlex ID | https://openalex.org/A5081926493 |
| Works | 112 |

## Researcher papers

- [Amyloid beta oligomers induce impairment of neuronal insulin receptors](https://scholariq.org/papers/amyloid-beta-oligomers-induce-impairment-of-neuronal-insulin-receptors/)

## Researcher topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Organoselenium and organotellurium chemistry](https://scholariq.org/topics/organoselenium-and-organotellurium-chemistry/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)
- [Sulfur-Based Synthesis Techniques](https://scholariq.org/topics/sulfur-based-synthesis-techniques/)

## Researcher university

- [Acumen Pharmaceuticals (United States)](https://scholariq.org/institutions/acumen-pharmaceuticals-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.